Skip to content

Breast Cancer Recurrence Risk Counseling

BRIM3: Breast Cancer Recurrence Risk Informational Materials Project

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03339518
Acronym
BRIM3
Enrollment
173
Registered
2017-11-13
Start date
2011-07-25
Completion date
2017-12-31
Last updated
2019-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Female

Brief summary

The number of breast cancer survivors is growing. Women with a personal history of breast cancer worry about their risk of getting cancer again. The current study will develop counseling about breast cancer recurrence risk and will also get an estimate of the preliminary impact of this counseling. The goal is to enable women to make better decisions about their treatment.

Interventions

BEHAVIORALBRIM3 educational intervention

Breast Cancer risk education and counseling

BEHAVIORALWait List

Booklet at the end of study

Sponsors

University of Kentucky
CollaboratorOTHER
West Virginia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women who (1) have a personal history of a single stage 0-2 breast cancer, (2) were recently diagnosed within the past 6 months, and (3) are treated at a participating breast oncology clinic.

Exclusion criteria

* Women who are unable to read/write in English.

Design outcomes

Primary

MeasureTime frameDescription
Comparative Perceived Risk of Breast Cancer6 monthsComparative perceived risk will be assessed with a comparative risk item (i.e., compared those of the same gender and race; Lipkus, CEBP 2000).
Absolute Perceived Risk of Breast Cancer6 monthsAbsolute perceived risk will be assessed with an absolute risk item to assess risk as a percentage (Kelly, PONC, 2005).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026